Is Your Fertility Doctor Taking Kickbacks?
By Cassie Murdoch,
| 07. 13. 2012
People take out loans to buy a car or a house or to send a child (or themselves) to college. And these days, more and more people are also taking out loans to create babies. It makes sense: A single cycle of IVF can run about $12,000, which, for most people, is A LOT of money. Responding to the growing IVF market, companies that give loans to fund fertility treatments are sprouting up across the country.
The Today Show
’s Dr. Nancy Snyderman recently filed a report
about the dozens of these fertility finance companies that are changing the way couples think about their options for having children. In theory, they’re just like any other loan company—except that they’re dealing with a population of borrowers who are often far more emotionally vulnerable than your average home buyer, and many of these lenders seem totally comfortable taking advantage of that fact. There are some that charge exorbitant interest rates, and others that are engaging in something far more unethical: Snyderman reports that some lenders are giving fertility doctors kickbacks or a...
By Françoise Baylis, Impact Ethics | 03.22.2023
By Ian Sample and Hannah Devlin, The Guardian | 03.06.2023
The next generation of advanced genetic therapies raises profound medical and ethical issues that must be thrashed out to ensure the game-changing technology benefits patients and society, a group of world-leading experts has warned.
Medicines based on powerful gene editing...
By Natasha Mitchell, ABC (feat. CGS' Katie Hasson) | 03.17.2023
Chinese scientist Dr Jiankui He flouted the law and bioethics basics to create the world's first CRISPR gene edited babies. Now out of jail, he's on Twitter recruiting patients and raising funds for more trials, this time in adults not embryos. An...
By Grace Browne, Wired [cites CGS' Katie Hasson] | 03.17.2023
Last Week in London, a small group of protestors braved it out in the rain in front of the Francis Crick Institute, where the Third International Summit on Human Genome Editing was taking place. The sparse congregation, from the group ...